Phio Pharmaceuticals Corp.

PHIO ·Healthcare, Drug Manufacturers - General, United States

SEC Filings

Form	Filed	Description
424B3	Apr 20, 2023	424(B)(3)
424B3	Apr 20, 2023	FORM 424(B)(3)
424B3	Apr 20, 2023	FORM 424(B)(3)
424B3	Apr 20, 2023	FORM 424(B)(3)
8-K	Apr 20, 2023	CURRENT REPORT
424B5	Apr 19, 2023	FORM 424(B)(5)
8-K	Apr 18, 2023	CURRENT REPORT
8-K	Apr 17, 2023	CURRENT REPORT
8-K	Mar 22, 2023	CURRENT REPORT
10-K	Mar 22, 2023	FORM 10-K
8-K	Mar 10, 2023	FORM 8-K
4	Mar 3, 2023	FORM 4 SUBMISSION
4	Feb 22, 2023	FORM 4 SUBMISSION
4	Feb 22, 2023	FORM 4 SUBMISSION
4	Feb 22, 2023	FORM 4 SUBMISSION
4	Feb 22, 2023	FORM 4 SUBMISSION
4	Feb 22, 2023	FORM 4 SUBMISSION
4	Feb 22, 2023	FORM 4 SUBMISSION
4	Feb 22, 2023	FORM 4 SUBMISSION
8-K	Feb 22, 2023	FORM 8-K
4	Feb 17, 2023	FORM 4 SUBMISSION
8-K	Feb 13, 2023	FORM 8-K
SC 13G/A	Feb 8, 2023	AMENDMENT NO. 3 TO SCHEDULE 13G
8-K	Jan 25, 2023	FORM 8-K
8-K	Jan 6, 2023	FORM 8-K

← Newer Page 10 of 36 · 891 filings Older →